BECTON, DICKINSON AND COMPANY Share-based Payment Arrangement, Expense
BECTON, DICKINSON AND COMPANY (BDX) reported Share-based Payment Arrangement, Expense of $262.00 million for the 12-month period ending 2025-09-30, per its 10-K filed 2025-11-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2025-11-25
- BECTON, DICKINSON AND COMPANY share-based payment arrangement, expense for the quarter ending 2017-09-30 was $39.00M, a 2.63% increase year-over-year.
- BECTON, DICKINSON AND COMPANY share-based payment arrangement, expense for the quarter ending 2017-06-30 was $39.00M, a 0.00% change year-over-year.
- BECTON, DICKINSON AND COMPANY share-based payment arrangement, expense for the quarter ending 2017-03-31 was $39.00M, a 9.30% decline year-over-year.
- BECTON, DICKINSON AND COMPANY share-based payment arrangement, expense for the quarter ending 2016-12-31 was $61.00M, a 19.74% decline year-over-year.
- BECTON, DICKINSON AND COMPANY share-based payment arrangement, expense for fiscal 2025 was $262.00M, a 5.22% increase from fiscal 2024.
- BECTON, DICKINSON AND COMPANY share-based payment arrangement, expense for fiscal 2024 was $249.00M, a 4.60% decline from fiscal 2023.
- BECTON, DICKINSON AND COMPANY share-based payment arrangement, expense for fiscal 2023 was $261.00M, a 8.75% increase from fiscal 2022.
- BECTON, DICKINSON AND COMPANY share-based payment arrangement, expense for fiscal 2022 was $240.00M, a 0.84% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | $262.00M 10-K · filed 2025-11-25 | |||||||
| 2024-09-30 | $249.00M 10-K · filed 2025-11-25 | |||||||
| 2023-09-30 | $261.00M 10-K · filed 2025-11-25 | |||||||
| 2022-09-30 | $240.00M 10-K · filed 2024-11-27 | |||||||
| 2021-09-30 | $238.00M 10-K · filed 2023-11-21 | |||||||
| 2020-09-30 | $245.00M 10-K · filed 2022-11-22 | |||||||
| 2019-09-30 | $265.00M 10-K · filed 2021-11-24 | |||||||
| 2018-09-30 | $332.00M 10-K · filed 2020-11-25 | |||||||
| 2017-09-30 | $39.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | $78.00M derived: sum of 2 quarters · filed 2019-11-27 | $117.00M derived: sum of 3 quarters · filed 2019-11-27 | $177.00M 10-K · filed 2019-11-27 | ||||
| 2017-06-30 | $39.00M 10-Q · filed 2017-08-03 | $78.00M derived: sum of 2 quarters · filed 2017-08-03 | $138.00M 10-Q · filed 2017-08-03 | $177.00M derived: sum of 4 quarters · filed 2018-11-21 | ||||
| 2017-03-31 | $39.00M 10-Q · filed 2017-05-02 | $99.00M 10-Q · filed 2017-05-02 | $138.00M derived: sum of 3 quarters · filed 2018-11-21 | $177.00M derived: sum of 4 quarters · filed 2018-11-21 | ||||
| 2016-12-31 | $61.00M 10-Q · filed 2017-02-02 | $99.00M derived: sum of 2 quarters · filed 2018-11-21 | $138.00M derived: sum of 3 quarters · filed 2018-11-21 | $181.00M derived: sum of 4 quarters · filed 2018-11-21 | ||||
| 2016-09-30 | $38.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-21 | $77.00M derived: sum of 2 quarters · filed 2018-11-21 | $120.00M derived: sum of 3 quarters · filed 2018-11-21 | $196.00M 10-K · filed 2018-11-21 | ||||
| 2016-06-30 | $39.00M 10-Q · filed 2017-08-03 | $82.00M derived: sum of 2 quarters · filed 2017-08-03 | $158.00M 10-Q · filed 2017-08-03 | $186.00M derived: sum of 4 quarters · filed 2017-11-22 | ||||
| 2016-03-31 | $43.00M 10-Q · filed 2017-05-02 | $119.00M 10-Q · filed 2017-05-02 | $147.00M derived: sum of 3 quarters · filed 2017-11-22 | $193.00M derived: sum of 4 quarters · filed 2017-11-22 | ||||
| 2015-12-31 | $76.00M 10-Q · filed 2017-02-02 | $104.00M derived: sum of 2 quarters · filed 2017-11-22 | $150.00M derived: sum of 3 quarters · filed 2017-11-22 | $194.00M derived: sum of 4 quarters · filed 2017-11-22 | ||||
| 2015-09-30 | $28.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-22 | $74.00M derived: sum of 2 quarters · filed 2017-11-22 | $118.00M derived: sum of 3 quarters · filed 2017-11-22 | $166.00M 10-K · filed 2017-11-22 | ||||
| 2015-06-30 | $46.00M 10-Q · filed 2016-08-04 | $90.00M derived: sum of 2 quarters · filed 2016-08-04 | $138.00M 10-Q · filed 2016-08-04 | $160.00M derived: sum of 4 quarters · filed 2016-11-23 | ||||
| 2015-03-31 | $44.00M 10-Q · filed 2016-05-06 | $92.00M 10-Q · filed 2016-05-06 | $114.00M derived: sum of 3 quarters · filed 2016-11-23 | $138.00M derived: sum of 4 quarters · filed 2016-11-23 | ||||
| 2014-12-31 | $48.00M 10-Q · filed 2016-02-05 | $70.00M derived: sum of 2 quarters · filed 2016-11-23 | $94.00M derived: sum of 3 quarters · filed 2016-11-23 | $119.00M derived: sum of 4 quarters · filed 2016-11-23 | ||||
| 2014-09-30 | $22.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-23 | $46.00M derived: sum of 2 quarters · filed 2016-11-23 | $71.00M derived: sum of 3 quarters · filed 2016-11-23 | $113.00M 10-K · filed 2016-11-23 | ||||
| 2014-06-30 | $24.00M 10-Q · filed 2015-08-06 | $49.00M derived: sum of 2 quarters · filed 2015-08-06 | $91.00M 10-Q · filed 2015-08-06 | $112.00M derived: sum of 4 quarters · filed 2015-11-25 | ||||
| 2014-03-31 | $25.00M 10-Q · filed 2015-05-08 | $67.00M 10-Q · filed 2015-05-08 | $88.00M derived: sum of 3 quarters · filed 2015-11-25 | $108.00M derived: sum of 4 quarters · filed 2015-11-25 | ||||
| 2013-12-31 | $42.00M 10-Q · filed 2015-02-06 | $63.00M derived: sum of 2 quarters · filed 2015-11-25 | $83.00M derived: sum of 3 quarters · filed 2015-11-25 | $104.43M derived: sum of 4 quarters · filed 2015-11-25 | ||||
| 2013-09-30 | $21.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-25 | $41.00M derived: sum of 2 quarters · filed 2015-11-25 | $62.43M derived: sum of 3 quarters · filed 2015-11-25 | $100.00M 10-K · filed 2015-11-25 | ||||
| 2013-06-30 | $20.00M 10-Q · filed 2014-08-04 | $20.48M 10-Q · filed 2013-08-05 | $41.43M derived: sum of 2 quarters · filed 2014-08-04 | $79.00M 10-Q · filed 2014-08-04 | $78.74M 10-Q · filed 2013-08-05 | $95.74M derived: sum of 4 quarters · filed 2015-03-13 | ||
| 2013-03-31 | $21.00M 10-Q · filed 2014-05-05 | $58.00M 10-Q · filed 2014-05-05 | $58.26M 10-Q · filed 2013-05-09 | $75.74M derived: sum of 3 quarters · filed 2015-03-13 | $93.80M derived: sum of 4 quarters · filed 2015-03-13 | |||
| 2012-12-31 | $37.00M 10-Q · filed 2014-02-10 | $36.84M 10-Q · filed 2013-02-07 | $54.31M derived: sum of 2 quarters · filed 2015-03-13 | $72.37M derived: sum of 3 quarters · filed 2015-03-13 | $91.64M derived: sum of 4 quarters · filed 2015-03-13 | |||
| 2012-09-30 | $17.31M derived: 8-K 12 month − 10-Q 9 month · filed 2015-03-13 | $35.37M derived: sum of 2 quarters · filed 2015-03-13 | $54.65M derived: sum of 3 quarters · filed 2015-03-13 | $89.00M 8-K · filed 2015-03-13 | $89.05M 10-K · filed 2012-11-21 | |||
| 2012-06-30 | $18.06M 10-Q · filed 2013-08-05 | $37.33M derived: sum of 2 quarters · filed 2013-08-05 | $71.69M 10-Q · filed 2013-08-05 | $72.49M derived: sum of 4 quarters · filed 2013-11-27 | ||||
| 2012-03-31 | $19.27M 10-Q · filed 2013-05-09 | $53.63M 10-Q · filed 2013-05-09 | $54.42M derived: sum of 3 quarters · filed 2013-11-27 | $72.91M derived: sum of 4 quarters · filed 2013-11-27 | ||||
| 2011-12-31 | $34.35M 10-Q · filed 2013-02-07 | $35.15M derived: sum of 2 quarters · filed 2013-11-27 | $53.63M derived: sum of 3 quarters · filed 2013-11-27 | $73.27M derived: sum of 4 quarters · filed 2013-11-27 | ||||
| 2011-09-30 | $798.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-11-27 | $19.28M derived: sum of 2 quarters · filed 2013-11-27 | $38.92M derived: sum of 3 quarters · filed 2013-11-27 | $73.00M 10-K · filed 2013-11-27 | $73.36M 10-K · filed 2011-11-23 | |||
| 2011-06-30 | $18.48M 10-Q · filed 2012-08-06 | $38.12M derived: sum of 2 quarters · filed 2012-08-06 | $72.20M 10-Q · filed 2012-08-06 | $82.46M derived: sum of 4 quarters · filed 2012-11-21 | ||||
| 2011-03-31 | $19.64M 10-Q · filed 2012-05-03 | $53.72M 10-Q · filed 2012-05-03 | $63.98M derived: sum of 3 quarters · filed 2012-11-21 | $80.63M derived: sum of 4 quarters · filed 2012-11-21 | ||||
| 2010-12-31 | $34.08M 10-Q · filed 2012-02-07 | $44.34M derived: sum of 2 quarters · filed 2012-11-21 | $60.99M derived: sum of 3 quarters · filed 2012-11-21 | $78.14M derived: sum of 4 quarters · filed 2012-11-21 | ||||
| 2010-09-30 | $10.26M derived: 10-K 12 month − 10-Q 9 month · filed 2012-11-21 | $26.91M derived: sum of 2 quarters · filed 2012-11-21 | $44.05M derived: sum of 3 quarters · filed 2012-11-21 | $79.37M 10-K · filed 2012-11-21 | ||||
| 2010-06-30 | $16.65M 10-Q · filed 2011-08-02 | $33.80M derived: sum of 2 quarters · filed 2011-08-02 | $69.12M 10-Q · filed 2011-08-02 | $76.71M derived: sum of 4 quarters · filed 2011-11-23 | ||||
| 2010-03-31 | $17.15M 10-Q · filed 2011-05-04 | $52.47M 10-Q · filed 2011-05-04 | $60.06M derived: sum of 3 quarters · filed 2011-11-23 | $82.57M derived: sum of 4 quarters · filed 2011-11-23 | ||||
| 2009-12-31 | $35.32M 10-Q · filed 2011-02-08 | $42.91M derived: sum of 2 quarters · filed 2011-11-23 | $65.42M derived: sum of 3 quarters · filed 2011-11-23 | |||||
| 2009-09-30 | $7.59M derived: 10-K 12 month − 10-Q 9 month · filed 2011-11-23 | $30.10M derived: sum of 2 quarters · filed 2011-11-23 | $86.57M 10-K · filed 2011-11-23 | |||||
| 2009-06-30 | $22.51M 10-Q · filed 2010-08-04 | $78.98M 10-Q · filed 2010-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |